Originally posted by Barrington314mx
View Post
We believe that the best results will come from the highest safe dose of umbilical cord blood cells combined with a single bolus of methylprednisolone and a 6-week course of lithium. Methylprednisolone (MP) should allow more of the transplanted cells to survive. A 6-week course of lithium shouldcause the transplanted cells to proliferate and also to produce growth factors that stimulate regeneration. Lithium has also been reported to stimulate regeneration of the spinal cord.
However, we did not know the safe dose of umbilical cord blood mononuclear cell transplants. That was why we started with 4-µliter injections and then progressed to 8 µliters and then to 16 µliters. In Hong Kong, we only did the 4- and 8-µliter injections and never got to the groups where we would give methylprednisolone or lithium.
Despite this, we saw remarkable white matter growth in the patients that received transplants. We saw clear gaps in all other patients before treatment. Of course this finding needs to be confirmed in many more subjects and confirmed by other measures of regeneration but these findings are amazing. Many scientists are excited by these results.
The slow growth of white matter was also expected but the extent of the growth was surprising. Axons grow no faster than a mm a day, and probably slower and the fact that we did not see the growth until 6-12 months after transplantation is not surprising. We were shocked by the amount of white matter growth. The MRI/DTI probably cannot detect fiber tracts that are less than a millimeter in diameter and I think that many of the white matter growth that we saw were several mm thick.
At 6 months, one of the subjects showed growth across the injury site and, to our enormous surprise, the growth seemed to have retracted at 12 months and then grew back at 18 months. This was shocking although, in retrospect, perhaps we should not be surprised that white matter can both grow forward and retract. It suggests much greater plasticity of white matter than we could have imagined. Of course, these findings must be replicated on larger series and confirmed with other methods of assessing white matter growth. If confirmed and the regrowth leads to functional improvement, this would be the first demonstration of regeneration in human spinal cord injury.
Finally, I don't know why Paolo and others don't understand that people can walk without changes in motor and sensory scores. I have been posting about the central pattern generator for over 15 years here on CareCure. Many people who recover walking after spinal cord injury cannot voluntarily move their legs or feel their legs as well as you would expect from their walking. We should also remember that this is very early in the trial and we may well see improved motor and sensory scores at 2 or even 3 years. The axons have to grow a long distance before they can restore function. I have been posting about how slow regeneration is for many years here.
So, I am actually quite reassured and excited by these results. The DTI images indicate that umbilical cord blood mononuclear cell transplants are causing regrowth of long tracts in the spinal cord, both ascending and descending. The fact that we are seing some early walking improvement although no motor or sensory score change is reassuring as well. If the results had shown earlier sensory and motor score recovery with no DTI evidence of white matter regrowth, it would have suggested that the treatment caused sprouting of surviving tracts that the MRI/DTI could not detect. This is less exciting than the finding that UCBMC are stimulating regeneration.
I am very anxious to see the last group of four patients transplanted with 16 µliters coupled with a bolus dose of methylprednsiolone and a 6-week course of lithium. We won't have the 6-month results on these patients until December. My staff will be in Kunming next week to help them enter the data. Through the entire month of November, the nurses have been flying or travelling to the patients' homes to do the examinations.
Wise.
Comment